ARTICLE SYNOPSIS...Regeneron Pharmaceuticals, Inc. (REGN) has been trading below its 50-day moving average since August 2017. Its stock, which once touched highs of 605, is now trading at 293. So what's in store for this stock? Is it wise to wait for an opportunity to